Advertisement

Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Organisation › Details

AbbVie Inc. (NYSE: ABBV)

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie employs more than 26,000 people worldwide and markets medicines in more than 170 countries. *

 

Period Start 2013-01-01 splitoff
  Group AbbVie (Group)
  Predecessor Abbott Laboratories Inc. (NYSE: ABT)
Product Industry pharmaceutical
     
Region Region Chicago, IL
  Country United States (USA)
  Street 1 N Waukegan Rd
  City 60064 North Chicago, IL
    Address record changed: 2019-09-11
     
Basic data Employees H: 10,001 to 50,00 (2015-03-30)
  Currency USD
  Annual sales 32,753,000,000 (revenues, net, consolidated (2018) 2018-12-31)
  Profit 5,687,000,000 (2018-12-31)
     
    * Document for �About Section�: BioMed X GmbH. (3/30/15). "Press Release: AbbVie and BioMed X Collaborate to Develop Novel Approaches for the Treatment of Alzheimer's Disease". Heidelberg.
     
   
Record changed: 2020-06-10

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for AbbVie (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2020 Digital Event CBPF2020 650x80




» top